All In MedTech

FDA Clearance Tracker · P850048-S002

TANDEM-R PSA IMMUNORADIOMETRIC ASSAY

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 10, 1987 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 10, 1987

Approved

Time to decision

136 days

Received Feb 24, 1987. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P850048-S002
Device name
TANDEM-R PSA IMMUNORADIOMETRIC ASSAY
Applicant location
Brea, CA
Received
Feb 24, 1987
Decided
Jul 10, 1987
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P850048

Device type

Device class
Class II
Regulation
21 CFR 866.6010

Every decision under product code LTJ

Source documents

Other decisions for Beckman Coulter, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.